BetterLife Pharma Inc. (CSE:BETR)

Canada flag Canada · Delayed Price · Currency is CAD
0.0600
+0.0050 (9.09%)
Dec 11, 2025, 9:52 AM EST
-42.86%
Market Cap8.27M
Revenue (ttm)n/a
Net Income (ttm)-839.95K
Shares Outn/a
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,000
Average Volume81,728
Open0.0550
Previous Close0.0550
Day's Range0.0550 - 0.0600
52-Week Range0.0450 - 0.1750
Beta1.06
RSI48.99
Earnings DateDec 29, 2025

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to t... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 7
Stock Exchange Canadian Securities Exchange
Ticker Symbol BETR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.